Inactivated Rabies Vaccine For Cat Bite Exposure Treatment

AIM Honor (Ningbo) Biopharmaceutical Co., Ltd. is a professional China manufacturer focusing on rabies prevention solutions. Inactivated Rabies Vaccine For Cat Bite Exposure Treatment provides reliable post-exposure vaccination support for people facing potential rabies risks caused by cat bites and scratches. With products supplied to more than 2000 CDC institutions and medical institutions across China, AIM Honor helps global partners strengthen rabies prevention systems.

After cat bites, scratches, or other possible rabies exposure incidents, timely medical intervention is essential. AIM Honor (Ningbo) Biopharmaceutical Co., Ltd. provides Inactivated Rabies Vaccine For Cat Bite Exposure Treatment as a professional vaccine solution for post-exposure prevention. As an experienced rabies vaccine supplier, AIM Honor develops Vero cell rabies vaccine products based on standardized manufacturing processes to support medical institutions and professional users.

Unlike preventive vaccination before exposure, post-exposure rabies prevention focuses on controlling infection risks after contact with potentially infected animals. Cat bites may cause direct tissue damage and create a pathway for rabies virus transmission, especially when the animal health condition is uncertain. Through timely wound management and vaccination procedures, exposure risks can be effectively managed under professional medical guidance.

Exposure Response

Cat bite incidents require rapid and standardized handling procedures. Whether caused by domestic cats, stray cats, or unknown-status animals, professional assessment is recommended after exposure. AIM Honor’s rabies vaccine products are designed to support healthcare providers in implementing post-exposure prevention strategies.

Immediate Actions After Exposure

After a cat bite or scratch occurs, correct first-aid procedures can reduce potential infection risks before medical treatment.

1. Wound cleaning: Wash the injured area with soap water or clean water for more than 15 minutes to remove contamination and reduce possible infection risks.

2. Wound disinfection: Apply iodophor or alcohol according to professional recommendations after cleaning.

3. Medical evaluation: Visit a qualified medical institution for exposure classification and professional rabies prevention advice.

Exposure Classification Guidance

Different cat-related injuries may require different prevention approaches. Healthcare professionals evaluate the exposure type, wound condition, and animal situation before determining the appropriate vaccination plan.

Category II exposure: Cat scratches without bleeding may still require attention because damaged skin may become a possible virus entry point.

Category III exposure: Cat bites with bleeding or saliva contact with damaged skin or mucous membranes represent higher-risk exposure situations and may require additional prevention measures according to professional assessment.

Product Function

Inactivated Rabies Vaccine For Cat Bite Exposure Treatment is an inactivated rabies vaccine solution based on Vero cell culture technology. After vaccination, the immune system is stimulated to produce protective antibodies against rabies virus, helping establish immune protection after possible exposure.

AIM Honor provides two Vero cell rabies vaccine solutions, including conventional vaccine and new generation serum-free Vero cell vaccine. These products are developed to meet different medical and procurement requirements while maintaining focus on safety, immunogenicity, and standardized production.

Immune Protection Mechanism

Rabies vaccination works by activating the body's immune response after administration. The vaccine introduces inactivated rabies virus components that cannot cause rabies but can stimulate immune recognition and antibody production.

According to the provided product information, AIM Honor vaccine products use strains with high immunogenicity. The conventional vaccine uses the indigenous aG strain, while the serum-free vaccine uses the PV-2061 strain.

The seroconversion rate reaches 100% at 14 days after vaccination according to the provided product data, and the neutralizing antibody level exceeds the WHO protective threshold of 0.5IU/ml, supporting effective immune response development after vaccination.

Medical Application

Post-exposure rabies prevention requires reliable products and professional medical support. AIM Honor’s vaccine solutions are suitable for different healthcare environments where rabies exposure management is required.

1. Hospitals and clinics: Medical institutions can provide standardized rabies prevention services for patients exposed to cat bites or scratches.

2. CDC organizations: Disease control institutions can utilize professional vaccine supply solutions for rabies prevention programs.

3. Emergency treatment scenarios: Individuals requiring post-exposure vaccination can receive professional medical evaluation and vaccination according to recommended procedures.

Technical Data

For professional buyers, medical institutions, and healthcare organizations, product specifications are important factors when selecting a rabies vaccine supplier. AIM Honor provides detailed product information based on the characteristics of conventional Vero cell rabies vaccine and serum-free Vero cell rabies vaccine.

Manufacturing Process

AIM Honor focuses on pharmaceutical manufacturing quality and process management. The production of rabies vaccine products follows standardized biological product manufacturing requirements, helping ensure consistency and reliability throughout the production process.

Vero Cell Technology

Vero cell culture technology is widely applied in vaccine production because of its stable biological production characteristics. AIM Honor uses Vero cell technology for rabies vaccine development and manufacturing, providing professional vaccine solutions for post-exposure prevention.

The conventional vaccine uses the indigenous aG strain, while the serum-free vaccine adopts the PV-2061 strain. Different technical routes allow AIM Honor to provide diversified product options for customers with different application requirements.

Safety Control Standards

Safety management is a key part of vaccine production. AIM Honor applies strict quality control procedures throughout manufacturing to support product reliability.

1. Raw material management: Production materials are controlled according to biological product manufacturing requirements.

2. Process control: Manufacturing procedures are managed through standardized production processes to maintain product consistency.

3. Product release: Product quality evaluation is conducted before market supply according to pharmaceutical requirements.

Quality Certification

AIM Honor (Ningbo) Biopharmaceutical Co., Ltd. has established professional capabilities in vaccine research, production, and supply. The company continues to improve biological product manufacturing systems and provide dependable rabies prevention solutions for healthcare partners.

According to the provided company information, the conventional rabies vaccine has obtained National Drug Approval Number S20073014 and maintained a 100% batch release qualification rate for 17 years.

The serum-free Vero cell rabies vaccine has completed Phase III clinical trials, and its marketing authorization application has been accepted by the Center for Drug Evaluation (CDE). The production process complies with WHO Specifications for the Use of Biological Products Raw Materials.

Procurement Benefits

Selecting a vaccine partner requires consideration of product capability, supply experience, and cooperation support. AIM Honor provides professional services for distributors, medical institutions, and healthcare organizations requiring stable rabies prevention products.

Supply Capability

AIM Honor’s rabies vaccine products have been supplied for a long time to more than 2000 CDC institutions and medical institutions across China. This supply experience supports professional cooperation with different healthcare partners.

For international customers, AIM Honor provides professional communication and cooperation support to help partners understand product information, application requirements, and supply arrangements.

Cooperation Advantages

1. Product diversity: Customers can select conventional Vero cell rabies vaccine or serum-free Vero cell rabies vaccine according to different requirements.

2. Professional experience: Long-term vaccine supply experience supports stable cooperation with medical organizations.

3. Technical support: AIM Honor provides professional product information and cooperation services for global partners.

Product Difference

Compared with general rabies prevention products, AIM Honor focuses on combining vaccine technology development with practical medical application needs. The two available vaccine solutions provide different choices for organizations managing rabies prevention programs.

Service Support

AIM Honor (Ningbo) Biopharmaceutical Co., Ltd. understands that vaccine procurement requires more than product supply. Professional communication, product information support, and stable cooperation services are also important parts of long-term partnerships.

For medical institutions, distributors, and healthcare organizations, AIM Honor provides professional cooperation support based on its experience in rabies vaccine production and supply. The company focuses on helping partners understand product characteristics, application requirements, and cooperation procedures.

Professional Partner Support

1. Product information support: AIM Honor provides detailed product information to help customers understand vaccine characteristics, technical routes, and application scenarios.

2. Supply coordination: The company supports communication and coordination for customers requiring stable rabies vaccine supply.

3. Professional cooperation: AIM Honor works with healthcare-related organizations to contribute to rabies prevention and control programs.

Brand Reliability

AIM Honor (Ningbo) Biopharmaceutical Co., Ltd. focuses on biological pharmaceutical development and vaccine manufacturing. Through continuous technology improvement and production management, the company provides professional rabies prevention solutions for different markets.

The company’s vaccine products have been supplied to more than 2000 CDC institutions and medical institutions across China, demonstrating practical experience in large-scale vaccine application and supply management.

For global customers searching for Inactivated Rabies Vaccine For Cat Bite Exposure Treatment, AIM Honor provides a combination of product capability, manufacturing experience, and professional cooperation support.

Common Questions

Q: Why is vaccination needed after a cat bite?

A: Cat bites can create a potential pathway for rabies virus transmission, especially when the animal’s health condition is unknown. After exposure, wound cleaning, professional evaluation, and vaccination according to medical recommendations are important steps for rabies prevention.

Q: Can cat scratches also require rabies prevention?

A: Cat scratches may also require attention because damaged skin can become a possible route of virus entry. The need for vaccination depends on exposure classification, wound condition, and animal information. Professional healthcare providers should evaluate each situation.

Q: What type of rabies vaccine technology does AIM Honor use?

A: AIM Honor uses Vero cell culture technology for rabies vaccine production. The company provides conventional Vero cell rabies vaccine and new generation serum-free Vero cell rabies vaccine options.

Q: How long does the rabies vaccination schedule usually take after exposure?

A: According to the provided product information, the commonly used five-dose intramuscular vaccination schedule for Category II and Category III exposure includes injections on days 0, 3, 7, 14, and 28. Healthcare professionals should determine the appropriate vaccination plan according to individual exposure conditions.

Q: What makes AIM Honor suitable for medical procurement?

A: AIM Honor combines vaccine manufacturing experience, product development capability, and stable supply experience. According to the provided company information, its rabies vaccine products have been supplied to more than 2000 CDC institutions and medical institutions across China.

Q: Does AIM Honor provide different rabies vaccine options?

A: Yes. AIM Honor provides both conventional Vero cell rabies vaccine and serum-free Vero cell rabies vaccine solutions. Different product options allow customers to select suitable solutions according to medical and procurement requirements.

Final Summary

Cat bite exposure requires timely prevention measures and reliable vaccine support. AIM Honor (Ningbo) Biopharmaceutical Co., Ltd. provides professional rabies vaccine solutions based on Vero cell technology, standardized manufacturing processes, and long-term supply experience.

For healthcare organizations and professional buyers looking for Inactivated Rabies Vaccine For Cat Bite Exposure Treatment, AIM Honor offers dependable product solutions and cooperation support. Through continuous innovation and quality management, the company contributes to improving rabies prevention and control worldwide.